Kilitch Drugs (India) Limited. - Company Profile

Q: Where is Kilitch Drugs (India) Limited. headquartered?

Kilitch Drugs (India) Limited. is headquartered at C 3012 Midc Ttc Indl Area Pawane, Thane, Maharashtra, 400705.

It is a pharma public limited company based in Thane, Maharashtra, India, established in 1992.

1992 Thane, Maharashtra, India Active

Last Updated: January 05, 2026

About Kilitch Drugs (India) Limited.

Kilitch Drugs (India) Limited., a active public limited company, was established on 12 May 1992 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239MH1992PLC066718. Registered under ROC Roc Mumbai. it is listed on BSE: 524500 and NSE: KILITCH. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹17.48 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹137.79 Cr and a net worth of ₹222.92 Cr. Employing 152 professional, Its leadership includes Dipen Jayantilal Jain (Director), Bhavin Mukund Mehta (Whole-Time Director), Mukund Prataprai Mehta (Managing Director). Past directors included Deepak Bhaskar Shenoy, Mahalingam Vasudevan, Dipen Jayantilal Jain. It holds ₹113.65 Cr open charges and ₹171.09 Cr settled loans. Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at C 301/2 Midc Ttc Indl Area Pawane, Thane, Maharashtra, 400705.

Company Details

CIN/LLPIN
L24239MH1992PLC066718
Registration Number
066718
Incorporation Date
12 May 1992
Authorized Capital
₹25.00 Cr
Paid-Up Capital
₹17.48 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 524500, NSE: KILITCH)
Company Status
Active

Key Metrics

Authorised Capital ₹ 25.00 Cr as on 05-01-2026
Paid Up Capital ₹ 17.48 Cr as on 05-01-2026
Company Age 33 Year, 9 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 113.65 Cr as on 05-01-2026
Satisfied Charges ₹ 171.09 Cr as on 05-01-2026
Revenue Growth **** 12.59% (FY 2024)
Profit Growth **** 11.81% (FY 2024)
Ebitda **** 20.25% (FY 2024)
Net Worth 13.78% (FY 2024)
Total Assets **** 13.89% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Kilitch Drugs (India) Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Kilitch Drugs (India) Limited.?

Current Directors

Name	Designation	Appointment Date	Status
Dipen Jayantilal Jain	Director	27 Aug 2024	Current
Bhavin Mukund Mehta	Whole-Time Director	29 Sep 2007	Current
Mukund Prataprai Mehta	Managing Director	12 May 1992	Current
Mira Bhavin Mehta	Managing Director	30 Sep 2014	Current
Vasudev Krishnamurti	Director	16 Mar 2018	Current
Venkita Subramanian Rajan	Director	28 Jun 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	22 Sep 2008	Past
Pramod Abcsdd	Director	10 Aug 2010	Past
Pramod Abcsdd	Additional Director	27 Aug 2024	Past
Pramod Abcsdd	Company Secretary	23 Sep 2008	Past
Pramod Abcsdd	Director	01 Sep 2012	Past
Pramod Abcsdd	Company Secretary	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kilitch Drugs (India).

Kilitch Drugs (India) Limited., for the financial year ended 2024, experienced significant growth in revenue, with a 12.59% increase. The company also saw a substantial improvement in profitability, with a 11.81% increase in profit. The company's net worth Soared by an impressive increase of 13.78%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

12.59%

*******

Revenue from Operations

*******

11.73%

*******

Total Assets

*******

13.89%

*******

Profit or Loss

*******

11.81%

*******

Net Worth

*******

13.78%

*******

EBITDA

*******

20.25%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kilitch Drugs (India)?

In 2024, Kilitch Drugs (India) had a promoter holding of 69.23% and a public holding of 30.76%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,136,500,000.00

Satisfied Charges

₹1,710,900,000.00

Charges Breakdown by Lending Institutions

Standard Chartered Bank : 38.25 Cr
Others : 37.90 Cr
Hdfc Bank Limited : 37.50 Cr

Latest Charge Details

Date	Lender	Amount	Status
21 Nov 2023	Standard Chartered Bank	₹37.50 Cr	Open
21 Oct 2023	Hdfc Bank Limited	₹37.50 Cr	Open
03 Oct 2022	Standard Chartered Bank	₹7.50 M	Open
03 Aug 2020	Others	₹2.90 Cr	Open
29 Apr 2015	Others	₹35.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Kilitch Drugs (India)?

Kilitch Drugs (India) has a workforce of 152 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Kilitch Drugs (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kilitch Drugs (India)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kilitch Drugs (India)

Recent Activity within the Organization

Charges

Progress on A charge with Standard Chartered Bank of Rs. 37.50 Cr registered on 21 Nov 2023 with Charge ID 100821297 was modified on 21 Dec 2024. was documented.
21 Dec 2024
Charges

A charge with Hdfc Bank Limited of Rs. 37.50 Cr registered on 21 Oct 2023 with Charge ID 100825253 was modified on 17 Oct 2024. was recorded as a recent event.
17 Oct 2024
Charges

Progress on A charge with Others of Rs. 35.00 Cr registered on 29 Apr 2015 with Charge ID 10579714 was modified on 17 Oct 2024. was documented.
17 Oct 2024
Annual General Meeting

Progress on Kilitch Drugs (India) Limited. last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was documented.
27 Sep 2024
Director Appointment

Dipen Jayantilal Jain was appointed as a Director was appointed as a Director on 27 Aug 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
27 Aug 2024
Balance Sheet

Kilitch Drugs (India) Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
31 Mar 2024

Explore recent activity and updates - View Recent Activity